Viking Therapeutics Stock Soars After Obesity Drug Delivers 22% Weight Loss
· gurufocus.com
Viking Therapeutics (VKTX) climbed more than 35% in premarket trading Tuesday after new data suggested patients using its experimental obesity drug VK2735 were
Viking Therapeutics (VKTX) climbed more than 35% in premarket trading Tuesday after new data suggested patients using its experimental obesity drug VK2735 were ...